eMethods. Supplemental Methods

tSNR/Motion Effects
One potential confound unique to fMRI research is that movement during image acquisition can degrade and affect the observed hemodynamic response. This can be an especially significant problem when one participant group has more motion than the other participant groups. One way to determine whether motion is a significant factor in observed group differences in the hemodynamic response is to examine the temporal signal-to-noise ratio (tSNR). The tSNR describes the temporal aspects of the fMRI acquisition. It is computed (on a voxelwise basis) as the ratio of the mean fMRI time course signal over its standard deviation. Motion will affect and degrade the tSNR. We therefore created tSNR maps for each participant by computing the mean at each voxel, the standard deviation of the detrended time series at each voxel, and then dividing the mean by the detrended standard deviation to get a tSNR value for each voxel. We then performed 3dANOVA within AFNI to determine if these maps differed between groups, using a threshold of P<.05 (corrected). A tSNR map for each group can be found in the eFigure. No significant group differences were observed, and we can therefore conclude that the tSNR values were not different between the 3 participant groups. If motion was different between the groups, it would have been reflected in these tSNR maps. We can therefore conclude that our results were due to differences in autobiographical recall and not to differential motion between the groups.
To directly compare head motion between groups, we first calculated the root mean square (RMS) motion and framewise displacement (FD) for each group. 1 We then calculated a 1-way ANOVA for the RMS and FD. The 1-way ANOVA revealed no difference in RMS motion (F 2,45 =0.60, P=.55), or FD (F 2,45 =0.65, P=.52) across groups. Group means for each measure can be found in eTable 1.
Fatigue Effects
The autobiographical memory (AM) task used in the current study consisted of ten 7minute runs. Taking into account setup, structural, and clinical MRI scans, a participant was in the fMRI machine for approximately 90 minutes. This raises the question of whether participant fatigue was a significant factor contributing to the observed results. To further examine this issue, 2 additional analyses were performed.
First, we examined participant ratings of fatigue (POMS fatigue subscale), alertness, and drowsiness (individual items from the VAS) collected prescan and postscan. A difference score was created for each participant, and each measure in which the scores obtained prescan were subtracted from the postscan scores (eTable 2). Positive values indicate an increase from prescan baseline, while negative values indicate a decrease from baseline. There was no significant change from 0 in any of these ratings for either all groups combined (t 47 <1.49, P>.142 for all) or each group examined individually (t 15 <0.74, P>.471 for all). Additionally, the groups did not differ from each other in the change in prescan to postscan on these scales (HC vs HR t 30 <1.21, P>.24 for all; HC vs MDD t 30 <1.23, P>.23 for all; HR vs MDD t 30 <0.65, P>.52 for all). Based on these measures, there was no evidence of increased fatigue following the fMRI task in any group, nor did the groups differ in the change in self-measures of fatigue prescan to postscan. Second, to determine whether the effects were equivalent at the start and end of the study, we reanalyzed the data to examine whether the proportion of specific or positive memories recalled was different between the first half (runs 1-5) and the second half (runs 6-10) of the task. We first performed a paired t test for each group comparing the proportion of specific and positive AMs recalled for the first and second half of the scan (see eTable 3 for group means). In no instance was this proportion different: HCs specific AMs first vs second half t 15 =1.55, P=.14, positive AMs first vs second half t 15 =0.54, P=.60; HRs specific AMs first vs second half t 15 =1.42, P=.18, positive AMs first vs second half t 15 =0.96, P=.35; MDDs specific AMs first vs second half t 15 =0.33, P=.75, positive AMs first vs second half t 15 =0.49, P=.96. Difference scores were created subtracting the percentage of specific and the percentage of positive memories recalled during the first half of the task from that recalled during the second half. Next, we performed an ANOVA with the between-group factors of diagnosis (HC, HR, MDD) and the dependent variable percentage of specific and percentage of positive AMs recalled. There was no group effect for either percentage of specific AMs recalled (F 2,45 =1.13, P=.33) or for percentage of positive AMs recalled (F 2,45 =1.07, P=.35). We also compared each group using an independent samples t test to confirm no significant difference was present (HC vs HR t 30 =0.20, P=.84 for change in percentage of specific AMs, t 30 =1.01, P=.32 for change in percentage of positive AMs. HC vs MDD t 30 =1.33, P=.20 for change in percent of specific AMs, t 30 =0.37, P=.71 for change in percentage of positive AMs. HR vs MDD t 30 =1.33, P=.20 for change in percentage of specific AMs, t 30 =1.42, P=.17 for change in percentage of positive AMs). Although the groups differed on overall percentage of specific and positive AMs recalled, there were no differences within groups in the proportion of these AMs recalled during the first and second half of the task. Therefore, we can conclude that the effects are equivalent at the start and end of the study.
Because participants fatigue scores did not change significantly following the task and because performance during the first and second half of the task was not different within each group, we can reasonably conclude that fatigue was not a significant factor influencing our results.
Additional Clinical Characteristics
Clinical characteristics of the MDD participants, including the presence of comorbid diagnoses, number of past major depressive episodes, and past antidepressant use, can be found in eTable 4. Approximately half of MDD participants had a comorbid diagnosis of an anxiety disorder. This total percentage, as well as the percentage of each comorbid anxiety disorder in our sample, is consistent with the National Comorbidity Survey, 2 indicating our MDD participant population is similar to that of the national MDD population in terms of comorbidities and increases our confidence in the generalizability of our findings. Research examining autobiographical memory and anxiety disorders has failed to replicate the overgenerality effect observed in patients with MDD (for a review of which disorders exhibit overgeneral autobiographical memory, the reader is referred to Williams et al, 2007 ). 3 Differences in autobiographical memory recall have not been found to occur between healthy controls and individuals with generalized anxiety disorder or social phobia, 3 which were common comorbid disorders in our MDD sample. In patients with both depression and anxiety, only depression has been found to predict the number of specific autobiographical memories recalled. 4 Our sample size did not afford the power to directly test whether different comorbid diagnosis influenced the results. However, based on the extant literature, we believe our results are specific to MDD and do not speak to the underlying pathology of anxiety, nor would they generalize to those patients whose primary diagnosis is an anxiety disorder without a comorbid depression diagnosis.
eFigure. tSNR Maps for Each Participant Group
Sagittal Section at x=19 showing mean temporal signal-to-noise ratio (tSNR) values for (a) healthy control (b) high-risk and (c) major depressive disorder participants.
eTable 1. Group Motion Statistics
Numbers in parentheses indicate one standard deviation of the mean. Abbreviations: FD = framewise displacement; HC = healthy control; HR = high-risk; MDD= major depressive disorder; RMS = root mean square. 
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